Probiotics for Preterm Neonates: What will it take to change clinical practice?

Neonatology

Volumn 105, Issue 1, 2013, Pages 64-70

  Ofek Shlomai, N ^a,f   Deshpande, G ^d,e   Rao, S ^b,c   Patole, S ^a,c  

^a KEM Hospital for Women   (Australia)

^b PRINCESS MARGARET HOSPITAL FOR CHILDREN   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d NEPEAN HOSPITAL   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Neonates; Practice; Probiotics; Routine

Indexed keywords

IMMUNOGLOBULIN A; PROBIOTIC AGENT;

ANTIBIOTIC RESISTANCE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CLINICAL PRACTICE; COLON FLORA; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; DRUG INDUCED DISEASE; DRUG SAFETY; ENTEROBACTER; EVIDENCE BASED PRACTICE; EXTREMELY LOW BIRTH WEIGHT; GENETIC STABILITY; HUMAN; INFECTION PREVENTION; KLEBSIELLA; LACTOBACILLUS REUTERI; META ANALYSIS (TOPIC); NECROTIZING ENTEROCOLITIS; NEWBORN; NEWBORN DEATH; NEWBORN SEPSIS; NONHUMAN; PREMATURITY; PRIMARY PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM HEMORRHAGE; REVIEW; SYSTEMATIC REVIEW (TOPIC); VERY LOW BIRTH WEIGHT; YEAST;

ENTEROCOLITIS, NECROTIZING; EVIDENCE-BASED MEDICINE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; PHYSICIAN'S PRACTICE PATTERNS; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 84898433426     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000354891     Document Type: Review

References (56)

1. Lemons JA, Bauer CR, Oh W, Korones SB, Papile LA, Stoll BJ, Verter J, Temprosa M, Wright LL, Ehrenkranz RA, Fanaroff AA, Stark A, Carlo W, Tyson JE, Donovan EF, Shankaran S, Stevenson DK: Very low birth weight outcomes of the National Institute of Child health and human development neonatal research network, January 1995 through December 1996. NICHD Neonatal Research Network. Pediatrics 2001; 107:E1.
2. Wang Q, Dong J, Zhu Y: Probiotic supplement reduces risk of necrotizing enterocolitis and mortality in preterm very low-birthweight infants: an updated meta-analysis of 20 randomized, controlled trials. J Pediatr Surg 2012; 47: 241-248.
3. Barrington KJ: Review: probiotics prevented necrotising enterocolitis and reduced mortality in preterm neonates. Arch Dis Child Educ Pract Ed 2011; 96: 199.
4. Tarnow-Mordi WO, Wilkinson D, Trivedi A, Brok J: Probiotics reduce all-cause mortality and necrotizing enterocolitis: it is time to change practice. Pediatrics 2010; 125: 1068-1070.
5. Alfaleh K, Anabrees J, Bassler D: Probiotics reduce the risk of necrotizing enterocolitis in preterm infants: a meta-analysis. Neonatology 2010; 97: 93-99.
6. Swanson JR: Necrotizing enterocolitis: is it time for zero tolerance? J Perinatol 2013; 33: 1-2.
7. Janvier A, Lantos J, Barrington K: The politics of probiotics: probiotics, necrotizing enterocolitis and the ethics of neonatal research. Acta Paediatr 2013; 102: 116-118.
8. Mihatsch WA, Vossbeck S, Eikmanns B, Hoegel J, Pohlandt F: Effect of Bifidobacterium lactis on the incidence of nosocomial infections in very-low-birth-weight infants: a randomized controlled trial. Neonatology 2010; 98: 156-163.
9. Kliegman RM: Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. J Pediatr 2005; 146: 710.
10. Awad H, Mokhtar H, Imam SS, Gad GI, Hafez H, Aboushady N: Comparison between killed and living probiotic usage versus placebo for the prevention of necrotizing enterocolitis and sepsis in neonates. Pak J Biol Sci 2010; 13: 253-262.
11. Bonsante F, Iacobelli S, Gouyon JB: Routine probiotic use in very preterm infants: retrospective comparison of two cohorts. Am J Perinatol 2013; 30: 41-46.
12. Hunter C, Dimaguila MA, Gal P, Wimmer JE Jr, Ransom JL, Carlos RQ, Smith M, Davanzo CC: Effect of routine probiotic, Lactobacillus reuteri DSM 17938, use on rates of necrotizing enterocolitis in neonates with birthweight 1000 grams: a sequential analysis. BMC Pediatr. 2012, 12, 142.
13. Luoto R, Isolauri E, Lehtonen L: Safety of Lactobacillus GG probiotic in infants with very low birth weight: twelve years of experience. Clin Infect Dis 2010; 50: 1327-1328.
14. Manzoni P, Lista G, Gallo E, Marangione P, Priolo C, Fontana P, Guardione R, Farina D: Routine Lactobacillus rhamnosus GG administration in VLBW infants: a retrospective, 6-year cohort study. Early Hum Dev 2011; 87(suppl 1):S35-S38.
15. Sari FN, Eras Z, Dizdar EA, Erdeve O, Oguz SS, Uras N, Dilmen U: Do oral probiotics affect growth and neurodevelopmental outcomes in very low-birth-weight preterm infants? Am J Perinatol 2012; 29: 579-586.
16. Chou IC, Kuo HT, Chang JS, Wu SF, Chiu HY, Su BH, Lin HC: Lack of effects of oral probiotics on growth and neurodevelopmental outcomes in preterm very low birth weight infants. J Pediatr 2010; 156: 393-396.
17. Romeo MG, Romeo DM, Trovato L, Oliveri S, Palermo F, Cota F, Betta P: Role of probiotics in the prevention of the enteric colonization by candida in preterm newborns: incidence of late-onset sepsis and neurological outcome. J Perinatol 2011; 31: 63-69.
18. Rouge C, Piloquet H, Butel MJ, Berger B, Rochat F, Ferraris L, Des Robert C, Legrand A, de la Cochetiere MF, N'Guyen JM, Vodovar M, Voyer M, Darmaun D, Roze JC: Oral supplementation with probiotics in very-lowbirth-weight preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2009; 89: 1828-1835.
19. Shanahan F: A commentary on the safety of probiotics. Gastroenterol Clin North Am 2012; 41: 869-876.
20. Prescott SL, Wiltschut J, Taylor A, Westcott L, Jung W, Currie H, Dunstan JA: Early markers of allergic disease in a primary prevention study using probiotics: 2.5-year follow-up phase. Allergy 2008; 63: 1481-1490.
21. Deshpande GC, Rao SC, Keil AD, Patole SK: Evidence-based guidelines for use of probiotics in preterm neonates. BMC Medicine 2011; 9: 92.
22. Deshpande GRS, Patole S, Bulsara M: Probiotics for prevention of necrotizing enterocolitis in preterm VLBW neonates-systematic review of randomised controlled trials. (update 2012). 4th Congress of the European Academy of Paediatric Societies (EAPS), Istanbul, 2012.
23. Deshpande G, Shingde V, Downe L, Leroi M, Xiao J: Routine probiotics for preterm neonates: experience in a tertiary Australian neonatal intensive care unit. J Paediatr Child Health 2013; 49: 50.
24. Vandenplas Y, Veereman-Wauters G: Probiotics: fishing in the ocean. J Pediatr Gastroenterol Nutr 2012; 54: 4-5.
25. Claud EC: First do no harm. J Pediatr Pharmacol Ther 2012; 17: 298-301.
26. Deshpande G, Rao S, Patole S, Bulsara M: Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 2010; 125: 921-930.
27. Jacobs SE, Tobin JM, Opie G, Donath S, Pirotta M, Tabrizi SN, Morley CJ, Garland SM, for the ProPrems Study Group: The Proprems randomised trial investigating the effects of probiotics on late onset sepsis in very preterm infants. Pediatric Academy Society Meeting (PAS), Washington, 2013.
28. Roberts D, Dalziel S: Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev 2006:CD004454.
29. McGuire W, Anthony MY: Donor human milk versus formula for preventing necrotising enterocolitis in preterm infants: systematic review. Arch Dis Child Fetal Neonatal Ed 2003; 88:F11-F14.
30. Patole SK, de Klerk N: Impact of standardised feeding regimens on incidence of neonatal necrotising enterocolitis: a systematic review and meta-analysis of observational studies. Arch Dis Child Fetal Neonatal Ed 2005; 90:F147-F151.
31. Bell EF, Acarregui MJ: Restricted versus liberal water intake for preventing morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2008:CD000503.
32. Pammi M, Abrams SA: Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2011:CD007137.
33. Darlow BA, Graham PJ: Vitamin A supplementation to prevent mortality and shortand long-term morbidity in very low birthweight infants. Cochrane Database Syst Rev 2011:CD000501.
34. Reuman PD, Duckworth DH, Smith KL, Kagan R, Bucciarelli RL, Ayoub EM: Lack of effect of Lactobacillus on gastrointestinal bacterial colonization in premature infants. Pediatr Infect Dis 1986; 5: 663-668.
35. Kitajima H, Sumida Y, Tanaka R, Yuki N, Takayama H, Fujimura M: Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 1997; 76:F101-F107.
36. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF: Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002; 82: 103-108.
37. Costalos C, Skouteri V, Gounaris A, Sevastiadou S, Triandafilidou A, Ekonomidou C, Kontaxaki F, Petrochilou V: Enteral feeding of premature infants with Saccharomyces boulardii. Early Hum Dev 2003; 74: 89-96.
38. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M, Hammerman C: Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005; 147: 192-196.
39. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF, Oh W: Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005; 115: 1-4.
40. Manzoni P, Mostert M, Leonessa ML, Priolo C, Farina D, Monetti C, Latino MA, Gomirato G: Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 2006; 42: 1735-1742.
41. Mohan R, Koebnick C, Schildt J, Schmidt S, Mueller M, Possner M, Radke M, Blaut M: Effects of Bifidobacterium lactis Bb12 supplementation on intestinal microbiota of preterm infants: a double-blind, placebo-controlled, randomized study. J Clin Microbiol 2006; 44: 4025-4031.
42. Stratiki Z, Costalos C, Sevastiadou S, Kastanidou O, Skouroliakou M, Giakoumatou A, Petrohilou V: The effect of a bifidobacter supplemented bovine milk on intestinal permeability of preterm infants. Early Hum Dev 2007; 83: 575-579.
43. Lin HC, Hsu CH, Chen HL, Chung MY, Hsu JF, Lien RI, Tsao LY, Chen CH, Su BH: Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial. Pediatrics 2008; 122: 693-700.
44. Samanta M, Sarkar M, Ghosh P, Ghosh J, Sinha M, Chatterjee S: Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns. J Trop Pediatr 2009; 55: 128-131.
45. Braga TD, da Silva GA, de Lira PI, de Car-valho Lima M: Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in verylow-birth-weight preterm infants: a doubleblind, randomized, controlled trial. Am J Clin Nutr 2011; 93: 81-86.
46. Hikaru U KS, Yayoi S, Hiromichi S, Hiroaki S, Yoshikazu O, Seigo S, Satoru N, Toshaiki S, Yuichiro Y: Bifidobacteria prevents preterm infants from developing infection and sepsis. Int J Probiotics Prebiotics 2010; 5: 33-36.
47. Sari FN, Dizdar EA, Oguz S, Erdeve O, Uras N, Dilmen U: Oral probiotics: Lactobacillus sporogenes for prevention of necrotizing enterocolitis in very low-birth weight infants: a randomized, controlled trial. Eur J Clin Nutr 2011; 65: 434-439.
48. Al-Hosni M, Duenas M, Hawk M, Stewart LA, Borghese RA, Cahoon M, Atwood L, Howard D, Ferrelli K, Soll R: Probiotics-supplemented feeding in extremely low-birth-weight infants. J Perinatol 2012; 32: 253-259.
49. Rojas MA, Lozano JM, Rojas MX, Rodriguez VA, Rondon MA, Bastidas JA, Perez LA, Rojas C, Ovalle O, Garcia-Harker JE, Tamayo ME, Ruiz GC, Ballesteros A, Archila MM, Arevalo M: Prophylactic probiotics to prevent death and nosocomial infection in preterm infants. Pediatrics 2012; 130:e1113-e1120.
50. Fernandez-Carrocera LA, Solis-Herrera A, Cabanillas-Ayon M, Gallardo-Sarmiento RB, Garcia-Perez CS, Montano-Rodriguez R, Echaniz-Aviles MO: Double-blind, randomised clinical assay to evaluate the efficacy of probiotics in preterm newborns weighing less than 1,500 g in the prevention of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed 2013; 98:F5-F9.
51. Sadowska-Krawczenko I KP, Polak A, Wietlicka-Piszcz M, Szajewska H: Lactobacilllus rhamnosus A TC A07FA for preventing necrotizing enterocolitis in very-low-birth-weight preterm infants: a randomized controlled trial (preliminary results). Pediatria Polska 2012; 87: 139-145.
52. Ke D, Su Z, Li L, et al: Effects of Bifico supplement for prevention of necrotizing enterocolitis in preterm infants: a randomized controlled trial. Chin Pediatr Emerg Med 2008; 12: 69-71.
53. Huang B YH, Huang X: Probiotics supplementation for prevention of necrotizing enterocolitis in very low birth weight neonates: a randomized controlled trial. J Guangdong Med Coll 2009; 27: 37-39.
54. Di MLX: Effects of bifidobacterium supplementation for prevention of necrotizing enterocolitis in preterm infants: a randomized controlled trial. Zhong Guo She Qu Yi Shi 2010; 231: 69.
55. Ren X, Na B, Ristow B, Whooley MA, Schiller NB: Usefulness of diastolic dominant pulmonary vein flow to predict hospitalization for heart failure and mortality in ambulatory patients with coronary heart disease (from the Heart and Soul Study). Am J Cardiol 2009; 103: 482-485.
56. Garland SM, Tobin JM, Pirotta M, Tabrizi SN, Opie G, Donath S, Tang ML, Morley CJ, Hickey L, Ung L, Jacobs SE: The ProPrems trial: investigating the effects of probiotics on late onset sepsis in very preterm infants. BMC Infect Dis 2011; 11: 210.